Article

More Genetic Clues Needed to Improve Lung Cancer Treatment

David Spigel, a lung cancer specialist, explains the potential of biomarkers in the search for new treatments.

David Spigel, director of the Lung Cancer Research Program at Sarah Cannon Research Institute in Nashville, answers CURE's questions on how biomarkers will affect lung cancer treatment now and in the future.

Podcast: David Spigel and the future of lung cancer biomarkers

While only a fraction of lung cancer mutations have a treatment that targets them, Spigel expects that in the near future, many more genetic clues will be uncovered. These discoveries will help shape treatment decisions for a wider range of patients.

Related Videos
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Image of man with grey hair.
Image of woman with blonde hair.
Image of woman with blonde hair.
Related Content
Illustration of woman with grey hair.
March 26th 2025

Surviving Scans While Surviving Breast Cancer

Felicia Mitchell
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of a pink ribbon.
March 21st 2025

Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer

Ryan Scott
Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky: © Konstanin Yuganov - stock.adobe.com.
March 20th 2025

What Patients With Breast Cancer Need to Know About Itovebi

Alex Biese
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.
Illustration of woman with brown hair.
March 20th 2025

A Heaven-Sent Sign About My Brother’s Lymphoma

Laura Yeager
Cancer runs in the family, and after I’d dealt with two breast cancers, my brother came down with lymphoma.